Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Stricker

Showing results (61-70 of 207) with videos related to

Pageof 21
Sort By:
Expert Review of Anti-Infective Therapy|October 5, 2007
Lyme disease: a turning pointRaphael B Stricker, Lorraine Johnson
The American Journal of Medicine|July 31, 2010
Persistent symptoms following treatment of early Lyme disease: false hope?Raphael B Stricker, Lorraine Johnson
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|December 3, 2010
The Lyme disease chronicles, continued. Chronic Lyme disease: in defense of the patient enterpriseRaphael B Stricker, Lorraine Johnson
Frontiers in Cellular and Infection Microbiology|August 23, 2013
Borrelia burgdorferi aggrecanase activity: more evidence for persistent infection in Lyme diseaseRaphael B Stricker, Lorraine Johnson
Lancet (London, England)|November 5, 1998
Fat accumulation and HIV-1 protease inhibitorsR B Stricker, B Goldberg
Philosophy, Ethics, and Humanities in Medicine : PEHM|June 10, 2010
The Infectious Diseases Society of America Lyme guidelines: a cautionary tale about the development of clinical practice guidelinesLorraine Johnson, Raphael B Stricker
Research in Virology|May 29, 1998
Weight gain associated with protease inhibitor therapy in HIV-infected patientsR B Stricker, B Goldberg
Expert Review of Anti-Infective Therapy|October 16, 2004
Treatment of Lyme disease: a medicolegal assessmentLorraine Johnson, Raphael B Stricker
Journal of the American Academy of Dermatology|April 3, 1999
Lichen nitidus and dinitrochlorabenzeneR B Stricker, B Goldberg
Immunology Letters|November 30, 1999
Apoptosis and HIV infection: T-cells fiddle while the immune system burnsB Goldberg, R B Stricker
Pageof 21

Showing results (61-70 of 207) with videos related to

Sort By:
Pageof 21
Expert Review of Anti-Infective Therapy|October 5, 2007
Lyme disease: a turning pointRaphael B Stricker, Lorraine Johnson
The American Journal of Medicine|July 31, 2010
Persistent symptoms following treatment of early Lyme disease: false hope?Raphael B Stricker, Lorraine Johnson
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|December 3, 2010
The Lyme disease chronicles, continued. Chronic Lyme disease: in defense of the patient enterpriseRaphael B Stricker, Lorraine Johnson
Frontiers in Cellular and Infection Microbiology|August 23, 2013
Borrelia burgdorferi aggrecanase activity: more evidence for persistent infection in Lyme diseaseRaphael B Stricker, Lorraine Johnson
Lancet (London, England)|November 5, 1998
Fat accumulation and HIV-1 protease inhibitorsR B Stricker, B Goldberg
Philosophy, Ethics, and Humanities in Medicine : PEHM|June 10, 2010
The Infectious Diseases Society of America Lyme guidelines: a cautionary tale about the development of clinical practice guidelinesLorraine Johnson, Raphael B Stricker
Research in Virology|May 29, 1998
Weight gain associated with protease inhibitor therapy in HIV-infected patientsR B Stricker, B Goldberg
Expert Review of Anti-Infective Therapy|October 16, 2004
Treatment of Lyme disease: a medicolegal assessmentLorraine Johnson, Raphael B Stricker
Journal of the American Academy of Dermatology|April 3, 1999
Lichen nitidus and dinitrochlorabenzeneR B Stricker, B Goldberg
Immunology Letters|November 30, 1999
Apoptosis and HIV infection: T-cells fiddle while the immune system burnsB Goldberg, R B Stricker
Pageof 21